Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by BostonGene Corporation
BostonGene to Participate in the European Federation of Laboratory Medicine Strategic Conference 2024
September 19, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene and Leading Global Cancer Institutions Announce Nature Publication
September 17, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024
September 13, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Honored as Gold and Silver Stevie® Award Winner in 2024 Stevie Awards for Technology Excellence
September 10, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene and Mount Sinai to Collaborate on a Prospective Precision Medicine Study of Patients with Multiple Myeloma
September 04, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Showcases AI-Powered Multiomics Platform and Advances in Immune System Profiling at 14th World Clinical Biomarkers & CDx Summit
August 28, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene and Collaborators Honored with GRASP Advocate Choice Award at the 2024 ASCO Annual Meeting
June 11, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Publication and Journal Cover Feature in Cancer Cell that Unveils a New Immune System Profiling Platform Stratifying Cancer Patients by Treatment Response
May 14, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Recognized as Designated Laboratory for the ComboMATCH Precision Medicine Clinical Trial
March 26, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Participation at the United States and Canadian Academy of Pathology 113th Annual Meeting
March 21, 2024
From
BostonGene Corporation
Via
Business Wire
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
March 05, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Publication in Nature
February 16, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene and Prisma Health Announce Collaboration Aimed at Predicting Efficacy of Immunotherapy in Rare Cancers
January 18, 2024
From
BostonGene Corporation
Via
Business Wire
BostonGene Named to the 2023 CB Insights' Digital Health 50 List
December 08, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s 2023 Annual Meeting
November 01, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene and Hokkaido University Hospital Collaborate to Develop Novel HER2 Protocols for Breast Cancer
September 19, 2023
From
BostonGene Corporation
Via
Business Wire
Patient Advocacy Group Awards BostonGene and Its Collaborators a GRASP Advocate Choice Award for 2023 ASCO Annual Meeting Poster
July 20, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene Highlights Approach to IO Research and Precision Medicine at the 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference
June 20, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene to Showcase Integrated Approach to Precision Medicine at PEGS Boston 2023
May 09, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene and Australia’s Mater Research Collaborate in New Follicular Lymphoma Study
May 02, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene Highlights Comprehensive Approach to Precision Medicine at hubXchange’s East Coast Genomics in Precision Oncology 2023
April 03, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Presentations at the United States and Canadian Academy of Pathology (USCAP) 112th Annual Meeting
March 07, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene Showcases Comprehensive Approach to Precision Medicine at Immuno-Oncology 360°
February 07, 2023
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Presentations at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
December 02, 2022
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Abstract Presentation at the Association for Molecular Pathology 2022 Annual Meeting
November 03, 2022
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces Strategic Alliance with the Massachusetts General Hospital Cancer Center
September 07, 2022
From
BostonGene Corporation
Via
Business Wire
BostonGene Announces New Master Agreement with Leading Cancer Center in New York City
July 12, 2022
From
BostonGene Corporation
Via
Business Wire
BostonGene and Thomas Jefferson University Announce Publication in Clinical Cancer Research Predicting Immunotherapy Response for Patients with Head and Neck Cancer
March 15, 2022
From
BostonGene Corporation
Via
Business Wire
BostonGene Expands Testing Capabilities to Predict Patient Response to Immunotherapy
February 08, 2022
From
BostonGene Corporation
Via
Business Wire
BostonGene and WellDyne Announce Strategic Partnership to Predict Immunotherapy Response and Reduce Overall Cost of Care in Cancer
January 11, 2022
From
BostonGene Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.